# Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI

> **NCT03186339** · — · COMPLETED · sponsor: **Institut für Pharmakologie und Präventive Medizin** · enrollment: 272 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **PROCEDURE:** TAVI
- **PROCEDURE:** SAVR
- **OTHER:** MM

## Key facts

- **NCT ID:** NCT03186339
- **Lead sponsor:** Institut für Pharmakologie und Präventive Medizin
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-08
- **Primary completion:** 2019-08-15
- **Final completion:** 2020-01-13
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2022-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03186339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03186339, "Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03186339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*